Industry: Pharmaceuticals, Biotechnology
Celladon Corporation is an exciting new biotechnology company focused on developing treatments for cardiovascular diseases through the application of scientific discoveries in molecular cardiology. Celladon is dedicated to the commercialization of innovative therapeutics based on the understanding of molecular cardiology. Breakthroughs in the basic understanding of the cardiovascular networks combined with powerful new biotechnological tools, have provided the foundation for new, rational, and technologically sophisticated approaches to cardiovascular therapeutics. The company’s first generation product enhances calcium cycling in the heart, delivered via a recombinant adeno-associated viral (rAAV) vector, as a treatment for congestive heart failure. ( www.celladon.net )
Celladon Corporation
2223 Avenida De La Playa #120
La Jolla, California 92037
USA
Tel: (858) 366-4288
Fax: (858) 964-0974